BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12931219)

  • 1. BRAF gene is not mutated in plasma cell leukemia and multiple myeloma.
    Bonello L; Voena C; Ladetto M; Boccadoro M; Palestro G; Inghirami G; Chiarle R
    Leukemia; 2003 Nov; 17(11):2238-40. PubMed ID: 12931219
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of BCL10 mutations in multiple myeloma and plasma cell leukemia.
    Shih LY; Fu JF; Shurtleff SA; Morris SW; Downing JR
    Genes Chromosomes Cancer; 2001 Apr; 30(4):402-6. PubMed ID: 11241793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
    Bezieau S; Devilder MC; Avet-Loiseau H; Mellerin MP; Puthier D; Pennarun E; Rapp MJ; Harousseau JL; Moisan JP; Bataille R
    Hum Mutat; 2001 Sep; 18(3):212-24. PubMed ID: 11524732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and RAS gene mutations in multiple myeloma.
    Portier M; Molès JP; Mazars GR; Jeanteur P; Bataille R; Klein B; Theillet C
    Oncogene; 1992 Dec; 7(12):2539-43. PubMed ID: 1461658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome studies in plasma cell leukemia and multiple myeloma in transformation.
    Jonveaux P; Berger R
    Genes Chromosomes Cancer; 1992 Jun; 4(4):321-5. PubMed ID: 1377939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cell leukemia 3 months after autologous blood cell transplantation for multiple myeloma.
    Koskela K; Pelliniemi TT; Lakkala T; Remes K
    Bone Marrow Transplant; 1998 Feb; 21(3):305-7. PubMed ID: 9489657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very low mutation frequency of exons 5-9 in the CARD11 gene from 186 adult acute leukemia and 31 multiple myeloma samples.
    Kim MS; Yoo NJ; Lee SH
    Leuk Res; 2011 May; 35(5):e46-7. PubMed ID: 21176849
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.
    Maura F; Petljak M; Lionetti M; Cifola I; Liang W; Pinatel E; Alexandrov LB; Fullam A; Martincorena I; Dawson KJ; Angelopoulos N; Samur MK; Szalat R; Zamora J; Tarpey P; Davies H; Corradini P; Anderson KC; Minvielle S; Neri A; Avet-Loiseau H; Keats J; Campbell PJ; Munshi NC; Bolli N
    Leukemia; 2018 Apr; 32(4):1044-1048. PubMed ID: 29209044
    [No Abstract]   [Full Text] [Related]  

  • 9. The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma.
    Fiedler W; Weh HJ; Suciu E; Wittlief C; Stocking C; Hossfeld DK
    Leukemia; 1990 Jul; 4(7):462-5. PubMed ID: 1695702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles.
    Mosca L; Musto P; Todoerti K; Barbieri M; Agnelli L; Fabris S; Tuana G; Lionetti M; Bonaparte E; Sirchia SM; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omedè P; Boccadoro M; Palumbo A; Neri A
    Am J Hematol; 2013 Jan; 88(1):16-23. PubMed ID: 23044976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14q+ marker chromosomes in multiple myeloma and plasma-cell leukaemia.
    Liang W; Rowley JD
    Lancet; 1978 Jan; 1(8055):96. PubMed ID: 74591
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma cell leukaemia mimicking acute monocytic leukaemia in the course of multiple myeloma.
    Eclache V; Lusina D; Lejeune F; Casassus P; Smadja N; Lortholary P
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):419-22. PubMed ID: 8414961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
    Corradini P; Inghirami G; Astolfi M; Ladetto M; Voena C; Ballerini P; Gu W; Nilsson K; Knowles DM; Boccadoro M
    Leukemia; 1994 May; 8(5):758-67. PubMed ID: 8182933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Marker-chromosome 14 in multiple myeloma and plasma-cell leukaemia.
    Wurster-Hill DH; McIntyre OR; Cornwell GG; Maurer LH
    Lancet; 1973 Nov; 302(7836):1031. PubMed ID: 4127256
    [No Abstract]   [Full Text] [Related]  

  • 15. Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation.
    Chang H; Yeung J; Xu W; Ning Y; Patterson B
    Br J Haematol; 2006 Sep; 134(6):613-5. PubMed ID: 16889615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia.
    Urashima M; Teoh G; Ogata A; Chauhan D; Treon SP; Sugimoto Y; Kaihara C; Matsuzaki M; Hoshi Y; DeCaprio JA; Anderson KC
    Clin Cancer Res; 1997 Nov; 3(11):2173-9. PubMed ID: 9815612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
    Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
    Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
    Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
    Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R171H missense mutation of INSL6 in a patient with spermatogenic failure.
    Chen GW; Luo X; Liu YL; Jiang Q; Qian XM; Guo ZY
    Eur J Med Genet; 2011; 54(4):e455-7. PubMed ID: 21616179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.